Skip to main content

Advertisement

Log in

Enhanced survival of human mesenchymal stem cells following co-delivery with glucagon-like peptide-1 analogue in fibrin gel

  • Research Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Here, we report that glucagon-like peptide-1 analogue liraglutide could enhance survival of human bone marrow-derived mesenchymal stem cells (hMSCs) following co-delivery in fibrin gel matrix. The hMSCs were treated with various concentrations (≤100 nM) of liraglutide. After 48 h, 100 nM liraglutide-treated hMSCs showed 1.4-fold higher cell viability than untreated hMSCs. Calcein staining for live cells and trypan blue staining for dead cells provided visual evidences that treatment of hMSCs with liraglutide increased cell survival. To evaluate the cell survival of hMSCs after in vivo transplantation, genomic DNA of hMSCs was quantified by quantitative real-time polymerase chain reaction by detecting human Alu element. Four days after transplantation, the survival of hMSCs co-transplanted with liraglutide (1.9 μg/kg) was 7.7-fold higher than that of plain hMSCs formulation. Taken together, our findings suggest the potential of liraglutide as a transplantation adjuvant for increasing in vivo survival of hMSCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Ade C, Roy-Engel AM, Deininger PL (2013) Alu elements: an intrinsic source of human genome instability. Curr Opin Virol 3:639–645

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L (2009) Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26 week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374:39–47

    Article  CAS  PubMed  Google Scholar 

  • Calarco A, Petillo O, Bosetti M, Torpedine A, Cannas M, Perrone L, Galderisi U, Melone MAB, Peluso G (2010) Controlled delivery of the heparan sulfate/FGF-2 complex by a polyelectrolyte scaffold promotes maximal hMSC proliferation and differentiation. J Cell Biochem 110:903–909

    Article  CAS  PubMed  Google Scholar 

  • Cheng K, Gupta S (2009) Quantitative tools for assessing the fate of xenotransplanted human stem/progenitor cells in chimeric mice. Xenotransplantation 16:145–151

    Article  PubMed Central  PubMed  Google Scholar 

  • Churro C, Pereira P, Vasconcelos V, Valério E (2012) Species-specific real-time PCR cell number quantification of the bloom-forming cyanobacterium Planktothrix agardhii. Arch Microbiol 194:749–757

    Article  CAS  PubMed  Google Scholar 

  • Croom K, McCormack P (2009) Liraglutide. Drugs 69:1985–2004

    Article  CAS  PubMed  Google Scholar 

  • Das R, Jahr H, van Osch GJ, Farrell E (2010) The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev 16:159–168

    Article  CAS  PubMed  Google Scholar 

  • Gu E, Chen WY, Gu J, Burridge P, Wu JC (2012) Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Theranostics 2:335–345

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gupta V (2013) Glucagon-like peptide-1 analogues: an overview. Indian J Endocrinol Metab 17:413–421

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Han W-N, Hölscher C, Yuan L, Yang W, Wang X-H, Wu M-N, Qi J-S (2011) Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats. Neurobiol Aging 34:576–588

    Article  Google Scholar 

  • Haque N, Rahman MT, Abu Kasim NH, Alabsi AM (2013) Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. Sci World J 2013:632972

    Article  Google Scholar 

  • Huang B, Qian J, Ma J, Huang Z, Shen Y, Chen X, Sun A, Ge J, Chen H (2014) Myocardial transfection of hypoxia-inducible factor-1 alpha and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res Ther 5:22

    Article  PubMed Central  PubMed  Google Scholar 

  • Li Z, Ni C-L, Yao Z, Chen L-M, Niu W-Y (2014) Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells. Metabolism 63:1022–1030

  • Lund A, Knop FK, Vilsbøll T (2014) Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities. Eur J Intern Med 25:407–414

    Article  CAS  PubMed  Google Scholar 

  • Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA (2007) In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25:220–227

    Article  CAS  PubMed  Google Scholar 

  • Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20:1297–1308

    Article  CAS  PubMed  Google Scholar 

  • Ramot Y, Meiron M, Toren A, Steiner M, Nyska A (2009) Safety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery. Toxicol Pathol 37:606–616

    Article  CAS  PubMed  Google Scholar 

  • Shao S, Nie M, Chen C, Chen X, Zhang M, Yuan G, Yu X, Yang Y (2014) Protective action of liraglutide in beta cells under lipotoxic stress via PI3 K/Akt/FoxO1 pathway. J Cell Biochem 115:1166–1175

    Article  CAS  PubMed  Google Scholar 

  • Sharma MK, Jalewa J, Hölscher C (2014a) Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress. J Neurochem 128:459–471

    Article  CAS  PubMed  Google Scholar 

  • Sharma RR, Pollock K, Hubel A, McKenna D (2014b) Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54:1418–1437

    Article  CAS  PubMed  Google Scholar 

  • Shim G, Im S, Lee S, Park JY, Kim J, Jin H, Lee S, Im I, Kim D-D, Kim SW, Lee TJ, Eom JS, Yi T-G, Song SU, Byun Y, Oh Y-K (2013) Enhanced survival of transplanted human adipose-derived stem cells by co-delivery with liposomal apoptosome inhibitor in fibrin gel matrix. Eur J Pharm Biopharm 85:673–681

    Article  CAS  PubMed  Google Scholar 

  • Spender LC, Inman GJ (2012) Phosphoinositide 3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt’s lymphoma cells to BH3 mimetics. Mol Cancer Res 10:347–359

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Toupet K, Maumus M, Peyrafitte J-A, Bourin P, van Lent PLEM, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D (2013) Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice. Arthritis Rheum 65:1786–1794

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Li C, Cheng K, Zhang R, Narsinh K, Li S, Li X, Qin X, Su T, Chen J, Cao F (2014) Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells (AD-MSCs) to attenuate myocardial ischemia injury through TLR4/NF-kappaB and Keap-1/Nrf2 signaling pathways. Antioxid Redox Signal. doi:10.1089/ars.2013.5683

    Google Scholar 

  • Yi T, Lee HJ, Cho YK, Jeon MS, Song SU (2014) Molecular characterization of neurally differentiated human bone marrow-derived clonal mesenchymal stem cells. Immune Netw 14:54–65

    Article  PubMed Central  PubMed  Google Scholar 

  • Yoo HS, Yi T, Cho YK, Kim WC, Song SU, Jeon MS (2013) Mesenchymal stem cell lines isolated by different isolation methods show variations in the regulation of graft-versus-host disease. Immune Netw 13:133–140

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

All authors (H. Jin, W. J. Lee, S. Lee, T. Yi, S. U. Song, G. Shim, Y.-K. Oh) declare that they have no conflict of interest. This work was supported by research grants from the Ministry of Science, ICT and Future Planning (NRF-2012R1A2A1A01007005), from the Korean Health Technology R&D Project (A092010), and from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A6A3A01026829).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gayong Shim or Yu-Kyoung Oh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jin, H., Lee, W.J., Lee, S. et al. Enhanced survival of human mesenchymal stem cells following co-delivery with glucagon-like peptide-1 analogue in fibrin gel. Journal of Pharmaceutical Investigation 45, 143–149 (2015). https://doi.org/10.1007/s40005-014-0156-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-014-0156-x

Keywords

Navigation